Dianthus Therapeutics, Inc.
DNTH
$85.74
-$0.41-0.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.11B | 404.30M | 402.61M | 257.39M | 263.23M |
| Total Receivables | 1.23M | 52.00K | 5.00M | 39.00K | 1.00M |
| Inventory | 4.42M | 3.03M | 3.84M | 3.94M | 4.31M |
| Prepaid Expenses | 2.92M | 1.97M | 2.30M | 2.12M | 2.07M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 83.00K | 86.00K | 73.00K | 111.00K | 392.00K |
| Total Current Assets | 1.12B | 409.44M | 413.83M | 263.61M | 271.00M |
|
|
|||||
| Total Current Assets | 1.12B | 409.44M | 413.83M | 263.61M | 271.00M |
| Net Property, Plant & Equipment | 1.57M | 1.63M | 1.49M | 1.59M | 1.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.19M | 9.72M | 8.85M | 9.18M | 7.64M |
| Total Assets | 1.25B | 530.92M | 577.45M | 326.08M | 348.58M |
|
|
|||||
| Total Accounts Payable | 5.27M | 9.73M | 6.71M | 5.40M | 8.27M |
| Total Accrued Expenses | 31.13M | 19.45M | 15.98M | 14.00M | 7.98M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 399.00K | 367.00K | 217.00K | 211.00K | 226.00K |
| Total Finance Division Other Current Liabilities | 1.49M | 1.19M | 954.00K | 479.00K | 479.00K |
| Total Other Current Liabilities | 1.49M | 1.19M | 954.00K | 479.00K | 479.00K |
| Total Current Liabilities | 38.28M | 30.73M | 23.86M | 20.09M | 16.95M |
|
|
|||||
| Total Current Liabilities | 38.28M | 30.73M | 23.86M | 20.09M | 16.95M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 965.00K | 1.02M | 1.07M | 1.12M | 1.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.32M | 5.77M | 6.07M | 1.79M | 1.85M |
| Total Liabilities | 45.57M | 37.52M | 30.99M | 23.00M | 19.97M |
|
|
|||||
| Common Stock & APIC | 1.58B | 829.64M | 818.59M | 538.51M | 532.24M |
| Retained Earnings | -377.56M | -336.73M | -272.30M | -235.53M | -203.90M |
| Treasury Stock & Other | -575.00K | 489.00K | 163.00K | 98.00K | 270.00K |
| Total Common Equity | 1.20B | 493.40M | 546.45M | 303.08M | 328.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.20B | 493.40M | 546.45M | 303.08M | 328.61M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.20B | 493.40M | 546.45M | 303.08M | 328.61M |
|
|
|||||